Invests in
Locations:
Min Investment:
$2,000,000.00Max Investment:
$50,000,000.00Target Investment:
$25,000,000.00
Skills
Education
Lists including Beth
Investments
Star Therapeutics
Series C
Total Funding: $90M
Kyverna Therapeutics
Series A
Total Funding: $170M
Kate Therapeutics
Series A
Total Funding: $51M
ACELYRIN
Series A
Total Funding: $560M
ArsenalBio
Series A
Total Funding: $310M
Neuron23
Series B
Total Funding: $210M
Electra Therapeutics
Series B
Total Funding: $84M
Expansion Therapeutics
Series A
Total Funding: $140M
Capsida
Series A
Total Funding: $50M
Sagimet Biosciences
Series B
Total Funding: $190M
Work Experience
Co-founding Managing Director at Westlake Village BioPartners
2018
2005
General Partner
2005
General partner at Kleiner Perkins focused on life science investing working with entrepreneurs to develop companies with breakthrough technology for treating patients and improving health.
2002 - 2005
Senior Vice President
2002 - 2005
Responsible for worldwide Clinical Development including Clinical Operations and Regulatory Affairs.
2000 - 2002
Senior Vice President, Global Development
2001 - 2002
Senior Vice President, Clinical Development & Life Cycle Management
2000 - 2001
Vice President, Clinical Immunology/Pulmonary/Dermatology
2000 - 2000
1989 - 2000
Vice President, Pulmonary-Immunology
1998 - 2000
Executive Director
1996 - 1998
Senior Director
1993 - 1996
Director, Clinical Pharmacology
1991 - 1993
Associate Director, Clinical Pharmacology
1989 - 1991